BMY vs JNJ
BMY and JNJ side by side — valuation & fundamentals (public data).
Key statistics
| Metric | BMYBRISTOL-MYERS SQUIBB COMPANY | JNJJohnson & Johnson |
|---|---|---|
| Market cap | $132.16B | $624.78B |
| P/E (TTM) | 14.3 | 30.1 |
| P/B | 5.92 | 7.35 |
| P/S | 2.7x | 6.6x |
| Dividend yield | 3.82% | 1.98% |
| Revenue | $49.19B(TTM) | $97.93B(TTM) |
| Revenue growth (YoY) | -0.2% | 6.0% |
| Net income | $9.28B(TTM) | $21.04B(TTM) |
| Earnings growth (YoY) | 178.8% | 90.6% |
| EPS, diluted | $4.54(TTM) | $8.62(TTM) |
| EBIT margin | 21.8% | 22.9% |
| ROE | 31.6% | 31.5% |
| ROIC | 14.0% | 16.1% |
| Piotroski F | 7/9 | 6/9 |
| 1y total return | +48.1% | +54.2% |
Figures from SEC filings · for reference only · not investment advice
Crecimiento de $10,000: BMY frente a JNJ
| Métrica | BMY | JNJ |
|---|---|---|
| Valor final | $13.9K | $31.4K |
| Retorno total | +39.1% | +213.7% |
| CAGR | +3.3% | +11.7% |
| Volatilidad | 25.2% | 18.5% |
| Sharpe | 0.10 | 0.48 |
| Sortino | 0.14 | 0.69 |
| Caída máxima | -47.7% | -27.4% |
Basado en 2600 días de negociación comunes, 2016-04-06 → 2026-08-07 · tasa libre de riesgo 3.87% (bono corto del Tesoro actual, mantenido constante)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)